Evidence map›Paper›PMID 37597727›Full record

ArticleJournal of immunological methods2023

MILKSHAKE Western blot and Sundae ELISA: We all scream for better antibody validation.

Qiana Mendez, Holland A Driscoll, Gregory R Mirando, Felicity Acca, Cassandra D Chapados, Kezzia S Jones, Michael Weiner, Xiaofeng Li, Mary R Ferguson

Open access · greenAbstract read
In one paragraph

Article in Journal of immunological methods, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Qiana MendezDepartment of Molecular Sciences, Abbratech, 25 Business Park Drive Branford, CT, USA. Electronic address: qmendez@abbratech.com.
Holland A DriscollDepartment of Molecular Sciences, Abbratech, 25 Business Park Drive Branford, CT, USA. Electronic address: hdriscoll@abbratech.com.
Gregory R MirandoDepartment of Molecular Sciences, Abbratech, 25 Business Park Drive Branford, CT, USA. Electronic address: gmirando@abbratech.com.
Felicity AccaDepartment of Molecular Sciences, Abbratech, 25 Business Park Drive Branford, CT, USA. Electronic address: facca@abbratech.com.
Cassandra D ChapadosDepartment of Molecular Sciences, Abbratech, 25 Business Park Drive Branford, CT, USA. Electronic address: cchapados@abbratech.com.
Kezzia S JonesDepartment of Molecular Sciences, Abbratech, 25 Business Park Drive Branford, CT, USA. Electronic address: kjones@abbratech.com.
Michael WeinerDepartment of Molecular Sciences, Abbratech, 25 Business Park Drive Branford, CT, USA. Electronic address: mweiner@abbratech.com.
Xiaofeng LiDepartment of Molecular Sciences, Abbratech, 25 Business Park Drive Branford, CT, USA. Electronic address: xli@abbratech.com.
Mary R FergusonDepartment of Molecular Sciences, Abbratech, 25 Business Park Drive Branford, CT, USA. Electronic address: mferguson@abbratech.com.
ABB (Switzerland) · CHABB (United States) · USAbbott Fund · USAbbott (United Kingdom) · GB

Funding

Method for the validation by Western analysis of affinity reagents against post-translationally modified proteins.R44GM146473 · NIGMS · ABBRATECH, INC. · PI WEINER, MICHAEL P · 2023 to 2024
$2.2M
Platform for the High Throughput Generation and Validation of Affinity ReagentsR44GM148998 · NIGMS · ABBRATECH, INC. · PI WEINER, MICHAEL P · 2023 to 2024
$2.2M
DIRECTED DISCOVERY AND VALIDATION OF ANTI-SPLICE-JUNCTION SITE AbsR44GM156476 · NIGMS · ABBRATECH, INC. · PI MICHAEL P WEINER · 2024 to 2026
$1.1M
Method for the validation by Western analysis of affinity reagents against post-translationally modified proteins. I. survey of existing antibodies, and II. development of method improvementsR43GM146473 · NIGMS · ABBRATECH, INC. · PI WEINER, MICHAEL P · 2022 to 2022
$339k
NIGMS NIH HHS R43 GM146473NIGMS NIH HHS R44 GM146473NIGMS NIH HHS R44 GM148998NIGMS NIH HHS R44 GM156476
6 · The paper itself

Abstract

Knowing that an antibody's sensitivity and specificity is accurate is crucial for reliable data collection. This certainty is especially difficult to achieve for antibodies (Abs) which bind post-translationally modified proteins. Here we describe two validation methods using surrogate proteins in western blot and ELISA. The first method, which we termed "MILKSHAKE" is a modified maltose binding protein, hence the name, that is enzymatically conjugated to a peptide from the chosen target which is either modified or non-modified at the residue of interest. The surety of the residue's modification status can be used to confirm Ab specificity to the target's post-translational modification (PTM). The second method uses a set of surrogate proteins, which we termed "Sundae". Sundae consists of a set of modified maltose binding proteins with a genetically encoded target sequence, each of which contains a single amino acid substitution at one position of interest. With Sundae, Abs can be evaluated for binding specificities to all twenty amino acids at a single position. Combining MILKSHAKE and Sundae methods, Ab specificity can be determined at a single-residue resolution. These data improve evaluation of commercially available Abs and identify off-target effects for Research-Use-Only and therapeutic Abs.

Indexed as

AntibodiesProtein Processing, Post-TranslationalAmino Acid SubstitutionBlotting, WesternEnzyme-Linked Immunosorbent AssayAntibodiesAntibodyELISAPost translational modificationValidationWestern blot

Identifiers

PMID37597727
PMCPMC10568614
OpenAlexW4385988492

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.